Insights

Strong Funding Backing Character Biosciences has secured over 110 million dollars in Series B funding, including significant investment from Sanofi Ventures, indicating strong investor confidence and financial stability that supports expansion and development of innovative therapies.

Strategic Partnerships The company's collaboration with major ophthalmology entities like Bausch + Lomb demonstrates an openness to strategic alliances, providing opportunities for joint ventures, licensing arrangements, and co-development initiatives in ophthalmic drug discovery.

Advanced Tech Platform Utilizing AI-driven genomics and multi-modal data integration, Character Biosciences offers a cutting-edge platform that can be valuable for pharmaceutical partners seeking to enhance their precision medicine pipelines and clinical trial efficiencies.

Market Focus on AMD With a dedicated focus on age-related macular degeneration and a deep phenotyping approach, there are opportunities to collaborate on targeted therapies, patient stratification, and personalized treatment strategies within the ophthalmology market.

Growth Potential Despite a relatively small team, the company’s rapidly progressing programs and recent funding rounds suggest high growth potential, making it an attractive partner for industries interested in innovative biotech solutions and early-stage drug development.

Character Biosciences Tech Stack

Character Biosciences uses 8 technology products and services including Google Ads, Google Drive, Google Workspace, and more. Explore Character Biosciences's tech stack below.

Google Ads

Advertising

Google Drive

Document Management Systems

Google Workspace

React

Javascript Frameworks

jQuery

Javascript Libraries

TensorFlow

Machine Learning

Microsoft

Miscellaneous

HSTS

Security

Character Biosciences Email Formats	Example	Percentage
First.Last@characterbio.com	John.Doe@characterbio.com	78%
First@characterbio.com	John@characterbio.com	19%
FLast@characterbio.com	JDoe@characterbio.com	3%

Character Biosciences Email Formats

Example

Percentage

First.Last@characterbio.com

John.Doe@characterbio.com

78%

First@characterbio.com

John@characterbio.com

19%

FLast@characterbio.com

JDoe@characterbio.com

Frequently Asked Questions

Where is Character Biosciences's headquarters located?

Character Biosciences's main headquarters is located at San Francisco, California 94103 United States. The company has employees across 1 continents, including North America.

What is Character Biosciences's official website and social media links?

Character Biosciences's official website is characterbio.com and has social profiles on LinkedIn.

What is Character Biosciences's SIC code NAICS code?

Character Biosciences's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Character Biosciences have currently?

As of April 2026, Character Biosciences has approximately 50 employees across 1 continents, including North America. Key team members include Chief Data And Analytics Officer: D. E.Vp Genetics And Data Sciences: M. V.Head Of People: J. W.. Explore Character Biosciences's employee directory with LeadIQ.

What industry does Character Biosciences belong to?

Character Biosciences operates in the Biotechnology Research industry.

What technology does Character Biosciences use?

Character Biosciences's tech stack includes Google AdsGoogle DriveGoogle WorkspaceReactjQueryTensorFlowMicrosoftHSTS.

What is Character Biosciences's email format?

Character Biosciences's email format typically follows the pattern of First.Last@characterbio.com. Find more Character Biosciences email formats with LeadIQ.

When was Character Biosciences founded?

Character Biosciences was founded in 2019.

Character Biosciences

Q: How many employees does Character Biosciences have currently?

Character Biosciences has approximately 50 employees.

Q: What technology does Character Biosciences use?

Character Biosciences's tech stack includes Microsoft, PyTorch, Loadable-Components, Amazon Web Services, Medium.

Q: What is Character Biosciences's NAICS code?

Character Biosciences's NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Biotechnology ResearchCalifornia, United States11-50 Employees

Character Biosciences is a precision medicine company transforming drug development for progressive, polygenic diseases, beginning with ophthalmology. Our mission is to identify the genetic and molecular drivers of disease progression so we can develop targeted therapies for patients who urgently need them. 

We've built one of the most comprehensive resources in age-related eye diseases by partnering with over 150 ophthalmology clinics to integrate genetics with longitudinal clinical and imaging data. This deep phenotyping approach enables us to reclassify complex diseases like age-related macular degeneration (AMD) into genetically defined subtypes, unlocking novel therapeutic targets and optimizing patient selection for clinical trials.

Character Bio’s AI-powered platform combines genomics, multi-modal data, and machine learning to discover and develop therapies that are more precise and more effective. Our lead programs, CTX114 and CTX203, are advancing toward clinical trials and are designed to slow or prevent vision loss in AMD patients.

We are committed to delivering a new generation of precision medicines to treat and ultimately cure age-related blindness.

Insights

Similar companies to Character Biosciences

Biogenesis